TD Cowen Upgrades Nektar Therapeutics (NKTR) to Outperform
Tweet Send to a Friend
TD Cowen analyst Chris Shibutani upgraded Nektar Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
